TIAF1 抗体 (AA 1-115)
Quick Overview for TIAF1 抗体 (AA 1-115) (ABIN7171970)
抗原
See all TIAF1 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-115
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- Antigen Affinity Purified
- 
                                            免疫原
- Recombinant Human TGFB1-induced anti-apoptotic factor 1 protein (1-115AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: IHC:1:20-1:200,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - TIAF1 (TGFB1-Induced Anti-Apoptotic Factor 1 (TIAF1))
- 
                                            别名
- TIAF1
- 
                                            背景
- 
                        Background: Inhibits the cytotoxic effects of TNF-alpha and overexpressed TNF receptor adapters TRADD, FADD, and RIPK1. Involved in TGF-beta1 inhibition of IkappaB-alpha expression and suppression of TNF-mediated IkappaB-alpha degradation. Aliases: TIAF1 antibody, TGFB1-induced anti-apoptotic factor 1 antibody, 12 kDa TGF-beta-1-induced antiapoptotic factor antibody 
- 
                                            UniProt
- O95411
 抗原
- 
                    
 
                                     
                                     
                                    